What are the implications of basal ganglia calcifications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Basal ganglia calcifications should be managed by treating the underlying cause and addressing symptoms to improve quality of life, as the calcifications themselves cannot be removed. When considering the management of basal ganglia calcifications, it is crucial to identify the underlying cause, as this will guide the treatment approach 1. The causes of basal ganglia calcifications can be diverse, including idiopathic basal ganglial calcification, hypoparathyroidism, pseudo-parathyroidism, and other metabolic abnormalities 1. In some cases, basal ganglia calcifications may be associated with secondary paroxysmal kinesigenic dyskinesia (PKD), a condition characterized by sudden, brief, and recurrent episodes of involuntary movements 1. Key points to consider in the management of basal ganglia calcifications include:

  • Identifying and treating the underlying cause, such as correcting calcium/phosphorus imbalances or managing parathyroid disorders 1
  • Addressing symptoms, such as movement disorders, cognitive impairment, psychiatric symptoms, or seizures, with targeted medications or therapies 1
  • Regular follow-up with neuroimaging and clinical assessment to monitor the progression of calcifications and adjust treatment as needed 1
  • Considering genetic counseling for familial cases 1 Ultimately, the goal of management is to improve quality of life by alleviating symptoms and addressing the underlying cause of basal ganglia calcifications.

From the Research

Basal Ganglia Calcifications

  • Basal ganglia calcifications can be physiological or pathological, with physiological calcifications occurring in about 0.3-1.5% of cases and being asymptomatic 2.
  • Pathological basal ganglia calcification can be due to various causes, including metabolic disorders, infectious and genetic diseases 2, 3.
  • The frequency of basal ganglia calcifications increases with age, particularly after 50 years old, and can be accompanied by neurological symptoms such as Parkinson's syndrome, psychiatric and cognitive disorders, epilepsy, or headache 3.

Causes of Basal Ganglia Calcifications

  • Hypoparathyroidism and pseudohypoparathyroidism are common causes of pathological basal ganglia calcification, presenting with symptoms such as tetany, seizures, parkinsonism, and dementia 2.
  • Infections such as toxoplasmosis, rubella, cytomegalovirus, cysticercosis, and AIDS can cause multiple and asymmetric intracranial calcifications 2, 4.
  • Inherited and neurodegenerative diseases, such as Cockayne syndrome, tuberous sclerosis, Fahr's syndrome, and Down syndrome, can cause symmetrical, bilateral basal ganglia calcification 2, 5, 6.

Diagnosis and Management

  • Basal ganglia calcifications can be detected incidentally by neuroimaging, and diagnosis involves analyzing calcification topography and studying different MRI sequences 3.
  • Serum concentration of calcium, phosphorus, and parathyroid hormone should be determined in all individuals with calcification of the basal ganglia to rule out hypoparathyroidism 2.
  • Treatment of underlying conditions, such as hypoparathyroidism, may lead to marked clinical improvement, and management of basal ganglia calcifications involves addressing the underlying cause 2, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Basal ganglia calcification].

La Revue de medecine interne, 2020

Research

Basal ganglia calcification: 'Fahr's disease'.

Practical neurology, 2025

Research

Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.